(19)
(11) EP 0 904 293 A1

(12)

(43) Date of publication:
31.03.1999 Bulletin 1999/13

(21) Application number: 97921538.0

(22) Date of filing: 23.05.1997
(51) International Patent Classification (IPC): 
C12N 15/ 09( . )
A61P 11/ 06( . )
A61P 37/ 06( . )
C07K 1/ 113( . )
C12P 21/ 02( . )
A61K 38/ 00( . )
A61P 37/ 04( . )
A61P 37/ 08( . )
C07K 14/ 54( . )
C12R 1/ 19( . )
(86) International application number:
PCT/AU1997/000322
(87) International publication number:
WO 1997/045448 (04.12.1997 Gazette 1997/52)
(84) Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 24.05.1996 AU 1996PO00054

(71) Applicants:
  • BresaGen Limited
    Thebarton, South Australia 5031 (AU)
  • MEDVET SCIENCE PTY. LTD.
    Adelaide, S.A. 5000 (AU)

(72) Inventors:
  • LOPEZ, Angel
    Medindie, S.A. 5081 (AU)
  • VADAS, Matthew
    Stirling, S.A. 5152 (AU)
  • SHANNON, Frances
    Crafers, S.A. 5152 (AU)
  • BASTIRAS, Stan
    Adelaide, S.A. 5000 (AU)
  • HEY, Allan, William
    Woodside, S.A. 5244 (AU)

(74) Representative: Jones, Elizabeth Louise 
Frank B. Dehn & Co., 179 Queen Victoria Street
London EC4V 4EL
London EC4V 4EL (GB)

   


(54) AN INTERLEUKIN-5 ANTAGONIST